Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly‐diagnosed with central nervous system atypical teratoid/rhabdoid tumors: The head start III experience
Pediatric Blood & Cancer2013Vol. 61(1), pp. 95–101
Citations Over TimeTop 10% of 2013 papers
Wafik Zaky, Girish Dhall, Lingyun Ji, Kelley Haley, Jeffrey C. Allen, Mark Atlas, Salvatore Bertolone, Albert Cornelius, Sharon L. Gardner, Ramesh Patel, Kamnesh R. Pradhan, Violet Shen, Stephen J. Thompson, Joseph C. Torkildson, Richard Sposto, Jonathan L. Finlay
Abstract
A minority of children with CNS AT/RT treated on HS III may be long-term survivors without irradiation. More effective therapies are desperately needed.
Related Papers
- → The effect of melphalan dose and total body irradiation as reduced-intensity conditioning for acute lymphoblastic leukemia patients undergoing allogeneic stem cell transplantation(2019)8 cited
- → Allogeneic marrow transplantation using fractionated total body irradiation in patients with acute lymphoblastic leukemia in relapse(1982)55 cited
- Successful pregnancy in a 28-year-old patient autografted for acute lymphoblastic leukemia following myeloablative treatment including total body irradiation.(1993)
- → Pulmonary complications of bone marrow transplantation (bmt): a comparison of total body irradiation & cyclophosphamide (TBI-CY) to busulfan & cyclophosphamh)e (BU-CY)(1993)1 cited
- → PO-1166 Total Body Irradiation (TBI) for hematopoietic stem cell transplantation(2023)